We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Oral Antibiotics Preferred for Pediatric Pneumonia

By Daniel Beris
Posted on 30 Nov 2016
Print article
Image: Research shows oral antibiotics following pneumonia in children show good results (Photo courtesy of Masterfile).
Image: Research shows oral antibiotics following pneumonia in children show good results (Photo courtesy of Masterfile).
Children with complicated pneumonia should be discharged from the hospital with oral instead of intravenous (IV) antibiotics when possible, according to a new study.

Researchers at Cincinnati Children's Hospital (OH, USA), the University of Pennsylvania (PA, USA), and other institutions conducted a multicenter retrospective cohort study of data from the Pediatric Health Information System (PHIS) to compare effectiveness and treatment-related complications of post-discharge antibiotics administered via a peripherally inserted central venous catheter (PICC), or administered orally. The study included 2,123 children from 36 hospitals who received oral (1,842) and PICC (281) antibiotics that were discharged with complicated pneumonia between 2009 and 2012.

The results showed no significant differences in treatment failure rates between PICC and oral antibiotics. Conversely, children discharged with PICCs experienced a higher rate of infections, adverse drug reactions, and hospital readmissions, with PICC complications occurring in 7.1% of children who received intravenous antibiotics. In addition, 17.8% of the children who received IV antibiotics required unplanned or emergency care, compared with only 3.1% of children who received oral antibiotics. The study was published on November 17, 2016, in Pediatrics.

“Children with complicated pneumonia typically require prolonged antibiotic therapy, 2 to 4 weeks in total, much of which is administered after hospital discharge. Our study demonstrates that oral antibiotics are just as effective as intravenous antibiotics, but with fewer treatment-associated complications,” said lead author Samir Shah, MD, of Cincinnati Children's Hospital. “This means that most children with complicated pneumonia can safely be discharged with antibiotics by mouth, avoiding the pain and potential complications associated with PICC lines.”

“One other factor to consider is that some antibiotics such as vancomycin can only be given by PICC. It is possible that the higher rate of adverse drug reactions in the PICC group, such as drug fever or low blood counts, were related to type of antibiotic used, rather than how it was given,” concluded Dr. Shah. “The reality is that one should consider the higher rate of adverse drug reactions in the PICC group, regardless of the reason, as one more factor favoring the use of antibiotics by mouth for complicated pneumonia.”

Related Links:
Cincinnati Children's Hospital
University of Pennsylvania
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Automated Cough Assist Device
Bionic Cough Simulator
New
Patient Monitor
Vista 300

Print article

Channels

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more